65 filings
Page 3 of 4
8-K
avuey7lkw3rrfvaa99
23 Mar 21
IDEAYA Biosciences, Inc. Reports Fourth Quarter 2020
6:03am
8-K
rmhx g2t9hrit3ax4j
17 Feb 21
IDEAYA Biosciences Appoints Susan L. Kelley, M.D., an Industry Veteran in Medical Oncology and Clinical Development, to its Board of Directors
6:05am
8-K
9lywwzjs
21 Jan 21
Entry into a Material Definitive Agreement
5:25pm
8-K
010s3va
19 Jan 21
Other Events
6:08am
8-K
ed1dxig
11 Jan 21
Regulation FD Disclosure
6:19am
8-K
fr2gci6z90u3
12 Nov 20
IDEAYA Biosciences, Inc. Reports Third Quarter 2020
6:06am
8-K
36wl1zqsh488w7s16ee
24 Sep 20
Entry into a Material Definitive Agreement
6:02am
8-K
u9uwvwy
12 Aug 20
IDEAYA Biosciences, Inc. Reports Second Quarter 2020
6:02am
8-K
nauv8eo
4 Aug 20
IDEAYA Announces HSR Clearance of GSK Strategic Partnership in Synthetic Lethality and Closing of Glaxo Group Equity Investment
6:04am
8-K
g1bv6 7rp
30 Jun 20
Departure of Directors or Certain Officers
6:05am
8-K
diz0ao9o8xeq1x3
22 Jun 20
Other Events
4:16pm
8-K
oazdj olhqldh
16 Jun 20
Submission of Matters to a Vote of Security Holders
4:35pm
8-K
b3v6j4x
16 Jun 20
IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology
6:02am
8-K
8i5s0nk0qlzvuix01f
12 May 20
IDEAYA Biosciences, Inc. Reports First Quarter 2020
6:05am
8-K
d0ffbk
7 Apr 20
Departure of Directors or Certain Officers
4:10pm
8-K
94zphe edetkud
24 Mar 20
IDEAYA Biosciences, Inc. Reports Fourth Quarter 2019
6:06am
8-K
k2bsfoqrhk8u98qyjeo
17 Mar 20
Entry into a Material Definitive Agreement
5:15pm
8-K
36gw p9fgjhrj
11 Mar 20
Entry into a Material Definitive Agreement
9:10am
8-K
6ulzln9
13 Jan 20
Regulation FD Disclosure
9:14am
8-K
kmo41e9 5nke
18 Dec 19
IDEAYA Biosciences Appoints Wendy Yarno to its Board of Directors
4:05pm